Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Cipla Ltd/India

+ Add to Watchlist

CIPLA:IN

661.10 INR 2.05 0.31%

As of 07:05:49 ET on 05/27/2015.

Snapshot for Cipla Ltd/India (CIPLA)

Open: 657.80 Day's Range: 652.85 - 669.65 Volume: 1,630,944
Previous Close: 659.05 52wk Range: 367.50 - 752.85 1-Yr Rtn: +75.70%

Stock Chart for CIPLA

No chart data available.
  • CIPLA:IN 661.10
  • 1D
  • 1M
  • 1Y
659.05
Interactive CIPLA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CIPLA

Current P/E Ratio (ttm) 38.2360
Estimated P/E(03/2015) 40.5657
Relative P/E vs. SENSEX 1.7777
Earnings Per Share (INR) (ttm) 17.2900
Est. EPS (INR) (03/2015) 16.2970
Est. PEG Ratio 1.3907
Market Cap (M INR) 530,837.15
Shares Outstanding (M) 802.96
30 Day Average Volume 2,075,409
Price/Book (mrq) 5.2815
Price/Sale (ttm) 5.2554
Dividend Indicated Gross Yield 0.30%
Cash Dividend (INR) 2.0000
Dividend Ex-Date 08/06/2014
5 Year Dividend Growth 0.00%
Next Earnings Announcement 05/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CIPLA

No data available

Company Profile & Key Executives for CIPLA

Cipla Limited manufactures and sells pharmaceutical and personal care products. The Company offers active pharmaceutical ingredients, and formulations in therapeutic areas, such as allergy, analgesic, anti malarial, anti-infectives, cardiology, dermatology and cosmeceuticals, diabetology, gastroenterology, steroids, iron chelators, nutritional products.

Subhanu SaxenaManaging Director/CEOKamil HamiedChief Strategy Officer
Mital SanghviSecretary/Compliance OfficerRajesh GargCFO/Executive Director
More Company Profile & Key Executives for CIPLA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil